213 related articles for article (PubMed ID: 2493979)
1. Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture.
Glikman P; Manni A; Demers L; Bartholomew M
Cancer Res; 1989 Mar; 49(6):1371-6. PubMed ID: 2493979
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the polyamine pathway in antiestrogen-induced growth inhibition of human breast cancer.
Cohen FJ; Manni A; Glikman P; Bartholomew M; Demers L
Cancer Res; 1988 Dec; 48(23):6819-25. PubMed ID: 3180091
[TBL] [Abstract][Full Text] [Related]
4. Role of polyamines in estradiol-induced growth of human breast cancer cells.
Lima G; Shiu RP
Cancer Res; 1985 Jun; 45(6):2466-70. PubMed ID: 3921243
[TBL] [Abstract][Full Text] [Related]
5. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic features of breast cancer cells overexpressing ornithine-decarboxylase.
Manni A; Wechter R; Wei L; Heitjan D; Demers L
J Cell Physiol; 1995 Apr; 163(1):129-36. PubMed ID: 7896889
[TBL] [Abstract][Full Text] [Related]
7. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo.
Hu X; Washington S; Verderame MF; Demers LM; Mauger D; Manni A
Int J Oncol; 2004 Dec; 25(6):1831-8. PubMed ID: 15547724
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion.
Seidenfeld J; Komar KA
Cancer Res; 1985 May; 45(5):2132-8. PubMed ID: 3921237
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effect of spermine depletion by N-cyclohexyl-1,3-diaminopropane in human breast cancer cells.
Huber M; Poulin R
Cancer Res; 1995 Feb; 55(4):934-43. PubMed ID: 7850811
[TBL] [Abstract][Full Text] [Related]
13. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
14. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
15. Role of polyamines in the growth of hormone-responsive and -resistant human breast cancer cells in nude mice.
Manni A; Badger B; Martel J; Demers L
Cancer Lett; 1992 Sep; 66(1):1-9. PubMed ID: 1451091
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
17. Polyamine involvement in the secretion and action of TGF-alpha in hormone sensitive human breast cancer cells in culture.
Kim I; Manni A; Lynch J; Demers L
Breast Cancer Res Treat; 1991 May; 18(2):83-91. PubMed ID: 1912611
[TBL] [Abstract][Full Text] [Related]
18. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells.
Das B; Rao AR; Madhubala R
Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003
[TBL] [Abstract][Full Text] [Related]
19. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
[TBL] [Abstract][Full Text] [Related]
20. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]